<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1992-12-01" modified="2017-05-10" version="203">
<accession>P29317</accession>
<accession>B5A968</accession>
<accession>Q8N3Z2</accession>
<name>EPHA2_HUMAN</name>
<protein>
<recommendedName>
<fullName>Ephrin type-A receptor 2</fullName>
<ecNumber>2.7.10.1</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Epithelial cell kinase</fullName>
</alternativeName>
<alternativeName>
<fullName>Tyrosine-protein kinase receptor ECK</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">EPHA2</name>
<name type="synonym">ECK</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1990" name="Mol. Cell. Biol." volume="10" first="6316" last="6324">
<title>cDNA cloning and characterization of eck, an epithelial cell receptor protein-tyrosine kinase in the eph/elk family of protein kinases.</title>
<authorList>
<person name="Lindberg R.A."/>
<person name="Hunter T."/>
</authorList>
<dbReference type="PubMed" id="2174105"/>
<dbReference type="DOI" id="10.1128/MCB.10.12.6316"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<source>
<tissue>Epithelium</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2008" name="Arthritis Res. Ther." volume="10" first="R73" last="R73">
<title>Novel splice variants derived from the receptor tyrosine kinase superfamily are potential therapeutics for rheumatoid arthritis.</title>
<authorList>
<person name="Jin P."/>
<person name="Zhang J."/>
<person name="Sumariwalla P.F."/>
<person name="Ni I."/>
<person name="Jorgensen B."/>
<person name="Crawford D."/>
<person name="Phillips S."/>
<person name="Feldmann M."/>
<person name="Shepard H.M."/>
<person name="Paleolog E.M."/>
</authorList>
<dbReference type="PubMed" id="18593464"/>
<dbReference type="DOI" id="10.1186/ar2447"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<scope>ALTERNATIVE SPLICING</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2006" name="Nature" volume="441" first="315" last="321">
<title>The DNA sequence and biological annotation of human chromosome 1.</title>
<authorList>
<person name="Gregory S.G."/>
<person name="Barlow K.F."/>
<person name="McLay K.E."/>
<person name="Kaul R."/>
<person name="Swarbreck D."/>
<person name="Dunham A."/>
<person name="Scott C.E."/>
<person name="Howe K.L."/>
<person name="Woodfine K."/>
<person name="Spencer C.C.A."/>
<person name="Jones M.C."/>
<person name="Gillson C."/>
<person name="Searle S."/>
<person name="Zhou Y."/>
<person name="Kokocinski F."/>
<person name="McDonald L."/>
<person name="Evans R."/>
<person name="Phillips K."/>
<person name="Atkinson A."/>
<person name="Cooper R."/>
<person name="Jones C."/>
<person name="Hall R.E."/>
<person name="Andrews T.D."/>
<person name="Lloyd C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Anderson F."/>
<person name="Andrew R.W."/>
<person name="Ashwell R.I.S."/>
<person name="Aubin K."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Beasley H."/>
<person name="Bethel G."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown J.Y."/>
<person name="Brown A.J."/>
<person name="Buckley D."/>
<person name="Burton J."/>
<person name="Bye J."/>
<person name="Carder C."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C."/>
<person name="Cobley V."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Coville G.J."/>
<person name="Davies J."/>
<person name="Deadman R."/>
<person name="Dunn M."/>
<person name="Earthrowl M."/>
<person name="Ellington A.G."/>
<person name="Errington H."/>
<person name="Frankish A."/>
<person name="Frankland J."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gay L."/>
<person name="Ghori M.R.J."/>
<person name="Gibson R."/>
<person name="Gilby L.M."/>
<person name="Gillett W."/>
<person name="Glithero R.J."/>
<person name="Grafham D.V."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Hammond S."/>
<person name="Harrison E.S.I."/>
<person name="Hart E."/>
<person name="Haugen E."/>
<person name="Heath P.D."/>
<person name="Holmes S."/>
<person name="Holt K."/>
<person name="Howden P.J."/>
<person name="Hunt A.R."/>
<person name="Hunt S.E."/>
<person name="Hunter G."/>
<person name="Isherwood J."/>
<person name="James R."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A."/>
<person name="Kay M."/>
<person name="Kershaw J.K."/>
<person name="Kibukawa M."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A.J."/>
<person name="Lad H."/>
<person name="Laird G."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Lloyd D.M."/>
<person name="Loveland J."/>
<person name="Lovell J."/>
<person name="Lush M.J."/>
<person name="Lyne R."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="Matthews N.S.W."/>
<person name="McLaren S."/>
<person name="Milne S."/>
<person name="Mistry S."/>
<person name="Moore M.J.F."/>
<person name="Nickerson T."/>
<person name="O'Dell C.N."/>
<person name="Oliver K."/>
<person name="Palmeiri A."/>
<person name="Palmer S.A."/>
<person name="Parker A."/>
<person name="Patel D."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phelps K."/>
<person name="Phillimore B.J."/>
<person name="Plumb R."/>
<person name="Rajan J."/>
<person name="Raymond C."/>
<person name="Rouse G."/>
<person name="Saenphimmachak C."/>
<person name="Sehra H.K."/>
<person name="Sheridan E."/>
<person name="Shownkeen R."/>
<person name="Sims S."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C."/>
<person name="Subramanian S."/>
<person name="Sycamore N."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Van Helmond Z."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="White S."/>
<person name="Whitehead S.L."/>
<person name="Wilkinson J.E."/>
<person name="Willey D.L."/>
<person name="Williams H."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Wu Z."/>
<person name="Coulson A."/>
<person name="Vaudin M."/>
<person name="Sulston J.E."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Wooster R."/>
<person name="Dunham I."/>
<person name="Carter N.P."/>
<person name="McVean G."/>
<person name="Ross M.T."/>
<person name="Harrow J."/>
<person name="Olson M.V."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Bentley D.R."/>
</authorList>
<dbReference type="PubMed" id="16710414"/>
<dbReference type="DOI" id="10.1038/nature04727"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Pancreas</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="1997" name="Cell" volume="90" first="403" last="404">
<title>Unified nomenclature for Eph family receptors and their ligands, the ephrins.</title>
<authorList>
<consortium name="Eph nomenclature committee"/>
</authorList>
<dbReference type="PubMed" id="9267020"/>
</citation>
<scope>NOMENCLATURE</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2000" name="Nat. Cell Biol." volume="2" first="62" last="69">
<title>Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation.</title>
<authorList>
<person name="Miao H."/>
<person name="Burnett E."/>
<person name="Kinch M."/>
<person name="Simon E."/>
<person name="Wang B."/>
</authorList>
<dbReference type="PubMed" id="10655584"/>
<dbReference type="DOI" id="10.1038/35000008"/>
</citation>
<scope>FUNCTION IN INTEGRIN-MEDIATED CELL ADHESION</scope>
<scope>FUNCTION IN CELL MIGRATION</scope>
<scope>PHOSPHORYLATION</scope>
<scope>INTERACTION WITH PTK2/FAK1 AND PTPN11</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2001" name="Cancer Res." volume="61" first="2301" last="2306">
<title>EphA2 overexpression causes tumorigenesis of mammary epithelial cells.</title>
<authorList>
<person name="Zelinski D.P."/>
<person name="Zantek N.D."/>
<person name="Stewart J.C."/>
<person name="Irizarry A.R."/>
<person name="Kinch M.S."/>
</authorList>
<dbReference type="PubMed" id="11280802"/>
</citation>
<scope>ONCOGENICITY</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="39274" last="39279">
<title>Regulation of the EphA2 kinase by the low molecular weight tyrosine phosphatase induces transformation.</title>
<authorList>
<person name="Kikawa K.D."/>
<person name="Vidale D.R."/>
<person name="Van Etten R.L."/>
<person name="Kinch M.S."/>
</authorList>
<dbReference type="PubMed" id="12167657"/>
<dbReference type="DOI" id="10.1074/jbc.M207127200"/>
</citation>
<scope>INTERACTION WITH ACP1</scope>
<scope>DEPHOSPHORYLATION BY ACP1</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="42375" last="42382">
<title>EphA2 phosphorylates the cytoplasmic tail of Claudin-4 and mediates paracellular permeability.</title>
<authorList>
<person name="Tanaka M."/>
<person name="Kamata R."/>
<person name="Sakai R."/>
</authorList>
<dbReference type="PubMed" id="16236711"/>
<dbReference type="DOI" id="10.1074/jbc.M503786200"/>
</citation>
<scope>FUNCTION IN CELL-CELL INTERACTION</scope>
<scope>INTERACTION WITH CLDN4</scope>
<scope>MUTAGENESIS OF LYS-646</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2007" name="Int. J. Oncol." volume="30" first="865" last="871">
<title>Ephrin-A1 is a negative regulator in glioma through down-regulation of EphA2 and FAK.</title>
<authorList>
<person name="Liu D.-P."/>
<person name="Wang Y."/>
<person name="Koeffler H.P."/>
<person name="Xie D."/>
</authorList>
<dbReference type="PubMed" id="17332925"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="2683" last="2694">
<title>Regulation of EphA2 receptor endocytosis by SHIP2 lipid phosphatase via phosphatidylinositol 3-Kinase-dependent Rac1 activation.</title>
<authorList>
<person name="Zhuang G."/>
<person name="Hunter S."/>
<person name="Hwang Y."/>
<person name="Chen J."/>
</authorList>
<dbReference type="PubMed" id="17135240"/>
<dbReference type="DOI" id="10.1074/jbc.M608509200"/>
</citation>
<scope>INTERACTION WITH INPPL1</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2008" name="Cancer Res." volume="68" first="1691" last="1696">
<title>EphA2 is an essential mediator of UV radiation-induced apoptosis.</title>
<authorList>
<person name="Zhang G."/>
<person name="Njauw C.-N."/>
<person name="Park J.M."/>
<person name="Naruse C."/>
<person name="Asano M."/>
<person name="Tsao H."/>
</authorList>
<dbReference type="PubMed" id="18339848"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-07-2372"/>
</citation>
<scope>FUNCTION IN APOPTOSIS</scope>
<scope>INDUCTION BY UV</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-570; SER-579 AND THR-647</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="15">
<citation type="journal article" date="2008" name="Oncogene" volume="27" first="7260" last="7273">
<title>Soluble monomeric EphrinA1 is released from tumor cells and is a functional ligand for the EphA2 receptor.</title>
<authorList>
<person name="Wykosky J."/>
<person name="Palma E."/>
<person name="Gibo D.M."/>
<person name="Ringler S."/>
<person name="Turner C.P."/>
<person name="Debinski W."/>
</authorList>
<dbReference type="PubMed" id="18794797"/>
<dbReference type="DOI" id="10.1038/onc.2008.328"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-570; SER-892 AND SER-901</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="2009" name="Cancer Cell" volume="16" first="9" last="20">
<title>EphA2 mediates ligand-dependent inhibition and ligand-independent promotion of cell migration and invasion via a reciprocal regulatory loop with Akt.</title>
<authorList>
<person name="Miao H."/>
<person name="Li D.Q."/>
<person name="Mukherjee A."/>
<person name="Guo H."/>
<person name="Petty A."/>
<person name="Cutter J."/>
<person name="Basilion J.P."/>
<person name="Sedor J."/>
<person name="Wu J."/>
<person name="Danielpour D."/>
<person name="Sloan A.E."/>
<person name="Cohen M.L."/>
<person name="Wang B."/>
</authorList>
<dbReference type="PubMed" id="19573808"/>
<dbReference type="DOI" id="10.1016/j.ccr.2009.04.009"/>
</citation>
<scope>DISEASE</scope>
<scope>FUNCTION IN CELL MIGRATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF ASP-739 AND SER-897</scope>
<scope>PHOSPHORYLATION AT SER-897 BY PKB</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2009" name="J. Proteome Res." volume="8" first="651" last="661">
<title>Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry.</title>
<authorList>
<person name="Chen R."/>
<person name="Jiang X."/>
<person name="Sun D."/>
<person name="Han G."/>
<person name="Wang F."/>
<person name="Ye M."/>
<person name="Wang L."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="19159218"/>
<dbReference type="DOI" id="10.1021/pr8008012"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-435</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="19">
<citation type="journal article" date="2009" name="Mol. Cancer Res." volume="7" first="1021" last="1032">
<title>Hsp90 is an essential regulator of EphA2 receptor stability and signaling: implications for cancer cell migration and metastasis.</title>
<authorList>
<person name="Annamalai B."/>
<person name="Liu X."/>
<person name="Gopal U."/>
<person name="Isaacs J.S."/>
</authorList>
<dbReference type="PubMed" id="19567782"/>
<dbReference type="DOI" id="10.1158/1541-7786.MCR-08-0582"/>
</citation>
<scope>UBIQUITINATION BY STUB1</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.M800588-MCP200"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-570; TYR-628; THR-647 AND SER-869</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2010" name="J. Cell Biol." volume="190" first="461" last="477">
<title>Ephexin4 and EphA2 mediate cell migration through a RhoG-dependent mechanism.</title>
<authorList>
<person name="Hiramoto-Yamaki N."/>
<person name="Takeuchi S."/>
<person name="Ueda S."/>
<person name="Harada K."/>
<person name="Fujimoto S."/>
<person name="Negishi M."/>
<person name="Katoh H."/>
</authorList>
<dbReference type="PubMed" id="20679435"/>
<dbReference type="DOI" id="10.1083/jcb.201005141"/>
</citation>
<scope>FUNCTION IN CELL MIGRATION</scope>
<scope>INTERACTION WITH ARHGEF16; DOCK4 AND ELMO2</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2010" name="Mol. Biol. Cell" volume="21" first="3902" last="3914">
<title>Ligand targeting of EphA2 enhances keratinocyte adhesion and differentiation via desmoglein 1.</title>
<authorList>
<person name="Lin S."/>
<person name="Gordon K."/>
<person name="Kaplan N."/>
<person name="Getsios S."/>
</authorList>
<dbReference type="PubMed" id="20861311"/>
<dbReference type="DOI" id="10.1091/mbc.E10-03-0242"/>
</citation>
<scope>FUNCTION IN KERATINOCYTE ADHESION AND DIFFERENTIATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="24">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2012" name="Biochemistry" volume="51" first="2136" last="2145">
<title>Solution structure of the first Sam domain of Odin and binding studies with the EphA2 receptor.</title>
<authorList>
<person name="Mercurio F.A."/>
<person name="Marasco D."/>
<person name="Pirone L."/>
<person name="Pedone E.M."/>
<person name="Pellecchia M."/>
<person name="Leone M."/>
</authorList>
<dbReference type="PubMed" id="22332920"/>
<dbReference type="DOI" id="10.1021/bi300141h"/>
</citation>
<scope>INTERACTION WITH ANKS1A</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2012" name="Nat. Med." volume="18" first="961" last="966">
<title>The ephrin receptor tyrosine kinase A2 is a cellular receptor for Kaposi's sarcoma-associated herpesvirus.</title>
<authorList>
<person name="Hahn A.S."/>
<person name="Kaufmann J.K."/>
<person name="Wies E."/>
<person name="Naschberger E."/>
<person name="Panteleev-Ivlev J."/>
<person name="Schmidt K."/>
<person name="Holzer A."/>
<person name="Schmidt M."/>
<person name="Chen J."/>
<person name="Konig S."/>
<person name="Ensser A."/>
<person name="Myoung J."/>
<person name="Brockmeyer N.H."/>
<person name="Sturzl M."/>
<person name="Fleckenstein B."/>
<person name="Neipel F."/>
</authorList>
<dbReference type="PubMed" id="22635007"/>
<dbReference type="DOI" id="10.1038/nm.2805"/>
</citation>
<scope>INTERACTION WITH HHV-8 GLYCOPROTEIN L/GLYCOPROTEIN H (MICROBIAL INFECTION)</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-575; SER-892; SER-897 AND SER-901</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="28">
<citation type="journal article" date="2013" name="Mol. Cell. Biol." volume="33" first="1430" last="1441">
<title>Receptor protein tyrosine phosphatase-receptor tyrosine kinase substrate screen identifies EphA2 as a target for LAR in cell migration.</title>
<authorList>
<person name="Lee H."/>
<person name="Bennett A.M."/>
</authorList>
<dbReference type="PubMed" id="23358419"/>
<dbReference type="DOI" id="10.1128/MCB.01708-12"/>
</citation>
<scope>FUNCTION IN CELL MIGRATION</scope>
<scope>PHOSPHORYLATION AT TYR-930</scope>
<scope>DEPHOSPHORYLATION AT TYR-930 BY PTPRF</scope>
<scope>INTERACTION WITH NCK1</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2013" name="PLoS ONE" volume="8" first="E69473" last="E69473">
<title>Early insights into the function of KIAA1199, a markedly overexpressed protein in human colorectal tumors.</title>
<authorList>
<person name="Tiwari A."/>
<person name="Schneider M."/>
<person name="Fiorino A."/>
<person name="Haider R."/>
<person name="Okoniewski M.J."/>
<person name="Roschitzki B."/>
<person name="Uzozie A."/>
<person name="Menigatti M."/>
<person name="Jiricny J."/>
<person name="Marra G."/>
</authorList>
<dbReference type="PubMed" id="23936024"/>
<dbReference type="DOI" id="10.1371/journal.pone.0069473"/>
</citation>
<scope>INTERACTION WITH CEMIP</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2015" name="Nat. Commun." volume="6" first="7679" last="7679">
<title>Crucial roles of RSK in cell motility by catalysing serine phosphorylation of EphA2.</title>
<authorList>
<person name="Zhou Y."/>
<person name="Yamada N."/>
<person name="Tanaka T."/>
<person name="Hori T."/>
<person name="Yokoyama S."/>
<person name="Hayakawa Y."/>
<person name="Yano S."/>
<person name="Fukuoka J."/>
<person name="Koizumi K."/>
<person name="Saiki I."/>
<person name="Sakurai H."/>
</authorList>
<dbReference type="PubMed" id="26158630"/>
<dbReference type="DOI" id="10.1038/ncomms8679"/>
</citation>
<scope>PHOSPHORYLATION AT SER-897 BY RPS6KA1 AND RPS6KA3</scope>
<scope>FUNCTION IN CELL MIGRATION</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2016" name="Mol. Biol. Cell" volume="27" first="2757" last="2770">
<title>Protein kinase A can block EphA2 receptor-mediated cell repulsion by increasing EphA2 S897 phosphorylation.</title>
<authorList>
<person name="Barquilla A."/>
<person name="Lamberto I."/>
<person name="Noberini R."/>
<person name="Heynen-Genel S."/>
<person name="Brill L.M."/>
<person name="Pasquale E.B."/>
</authorList>
<dbReference type="PubMed" id="27385333"/>
<dbReference type="DOI" id="10.1091/mbc.E16-01-0048"/>
</citation>
<scope>PHOSPHORYLATION AT SER-897 BY PKA</scope>
<scope>PHOSPHORYLATION AT SER-901</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2002" name="Structure" volume="10" first="1659" last="1667">
<title>Structures of the cancer-related Aurora-A, FAK, and EphA2 protein kinases from nanovolume crystallography.</title>
<authorList>
<person name="Nowakowski J."/>
<person name="Cronin C.N."/>
<person name="McRee D.E."/>
<person name="Knuth M.W."/>
<person name="Nelson C.G."/>
<person name="Pavletich N.P."/>
<person name="Rogers J."/>
<person name="Sang B.C."/>
<person name="Scheibe D.N."/>
<person name="Swanson R.V."/>
<person name="Thompson D.A."/>
</authorList>
<dbReference type="PubMed" id="12467573"/>
<dbReference type="DOI" id="10.1016/S0969-2126(02)00907-3"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 596-900</scope>
</reference>
<reference key="33">
<citation type="submission" date="2008-01" db="PDB data bank">
<title>Solution structure of the C-terminal SAM-domain of EPHAA2: ephrin type-A receptor 2 precursor (EC 2.7.10.1).</title>
<authorList>
<consortium name="RIKEN structural genomics initiative (RSGI)"/>
</authorList>
</citation>
<scope>STRUCTURE BY NMR OF 902-976</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2009" name="EMBO Rep." volume="10" first="722" last="728">
<title>Ligand recognition by A-class Eph receptors: crystal structures of the EphA2 ligand-binding domain and the EphA2/ephrin-A1 complex.</title>
<authorList>
<person name="Himanen J.P."/>
<person name="Goldgur Y."/>
<person name="Miao H."/>
<person name="Myshkin E."/>
<person name="Guo H."/>
<person name="Buck M."/>
<person name="Nguyen M."/>
<person name="Rajashankar K.R."/>
<person name="Wang B."/>
<person name="Nikolov D.B."/>
</authorList>
<dbReference type="PubMed" id="19525919"/>
<dbReference type="DOI" id="10.1038/embor.2009.91"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.52 ANGSTROMS) OF 28-201</scope>
<scope>X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 28-201 IN COMPLEX WITH EFNA1</scope>
<scope>SUBUNIT</scope>
<scope>DISULFIDE BOND</scope>
<scope>MUTAGENESIS OF ARG-103</scope>
</reference>
<reference key="35">
<citation type="submission" date="2009-02" db="PDB data bank">
<title>Ephrin A1 bound to the ligand binding domain of the human ephrin A2 (EPHA2) receptor protein kinase.</title>
<authorList>
<consortium name="Structural genomics consortium (SGC)"/>
</authorList>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 25-202</scope>
<scope>DISULFIDE BOND</scope>
</reference>
<reference key="36">
<citation type="submission" date="2009-08" db="PDB data bank">
<title>Left-handed dimer of EPHA2 transmembrane domain helix packing diversity among receptor tyrosine kinases.</title>
<authorList>
<person name="Mayzel M.L."/>
<person name="Bocharov E.V."/>
<person name="Volynsky P.E."/>
<person name="Arseniev A.S."/>
</authorList>
</citation>
<scope>STRUCTURE BY NMR OF 523-563</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2010" name="Proc. Natl. Acad. Sci. U.S.A." volume="107" first="10860" last="10865">
<title>Architecture of Eph receptor clusters.</title>
<authorList>
<person name="Himanen J.P."/>
<person name="Yermekbayeva L."/>
<person name="Janes P.W."/>
<person name="Walker J.R."/>
<person name="Xu K."/>
<person name="Atapattu L."/>
<person name="Rajashankar K.R."/>
<person name="Mensinga A."/>
<person name="Lackmann M."/>
<person name="Nikolov D.B."/>
<person name="Dhe-Paganon S."/>
</authorList>
<dbReference type="PubMed" id="20505120"/>
<dbReference type="DOI" id="10.1073/pnas.1004148107"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.65 ANGSTROMS) OF 23-202 IN COMPLEX WITH EFNA1</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] ARG-391; MET-511; HIS-568; SER-777 AND HIS-876</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2008" name="Mol. Vis." volume="14" first="2042" last="2055">
<title>The EPHA2 gene is associated with cataracts linked to chromosome 1p.</title>
<authorList>
<person name="Shiels A."/>
<person name="Bennett T.M."/>
<person name="Knopf H.L.S."/>
<person name="Maraini G."/>
<person name="Li A."/>
<person name="Jiao X."/>
<person name="Hejtmancik J.F."/>
</authorList>
<dbReference type="PubMed" id="19005574"/>
</citation>
<scope>VARIANT CTRCT6 TRP-948</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2009" name="Hum. Mutat." volume="30" first="E603" last="E611">
<title>Mutations of the EPHA2 receptor tyrosine kinase gene cause autosomal dominant congenital cataract.</title>
<authorList>
<person name="Zhang T."/>
<person name="Hua R."/>
<person name="Xiao W."/>
<person name="Burdon K.P."/>
<person name="Bhattacharya S.S."/>
<person name="Craig J.E."/>
<person name="Shang D."/>
<person name="Zhao X."/>
<person name="Mackey D.A."/>
<person name="Moore A.T."/>
<person name="Luo Y."/>
<person name="Zhang J."/>
<person name="Zhang X."/>
</authorList>
<dbReference type="PubMed" id="19306328"/>
<dbReference type="DOI" id="10.1002/humu.20995"/>
</citation>
<scope>VARIANT CTRCT6 ILE-940</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2009" name="PLoS Genet." volume="5" first="E1000584" last="E1000584">
<title>EPHA2 is associated with age-related cortical cataract in mice and humans.</title>
<authorList>
<person name="Jun G."/>
<person name="Guo H."/>
<person name="Klein B.E."/>
<person name="Klein R."/>
<person name="Wang J.J."/>
<person name="Mitchell P."/>
<person name="Miao H."/>
<person name="Lee K.E."/>
<person name="Joshi T."/>
<person name="Buck M."/>
<person name="Chugha P."/>
<person name="Bardenstein D."/>
<person name="Klein A.P."/>
<person name="Bailey-Wilson J.E."/>
<person name="Gong X."/>
<person name="Spector T.D."/>
<person name="Andrew T."/>
<person name="Hammond C.J."/>
<person name="Elston R.C."/>
<person name="Iyengar S.K."/>
<person name="Wang B."/>
</authorList>
<dbReference type="PubMed" id="19649315"/>
<dbReference type="DOI" id="10.1371/journal.pgen.1000584"/>
</citation>
<scope>VARIANT CTRCT6 GLN-721</scope>
<scope>CHARACTERIZATION OF VARIANT CTRCT6 GLN-721</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2012" name="PLoS ONE" volume="7" first="E36564" last="E36564">
<title>Human cataract mutations in EPHA2 SAM domain alter receptor stability and function.</title>
<authorList>
<person name="Park J.E."/>
<person name="Son A.I."/>
<person name="Hua R."/>
<person name="Wang L."/>
<person name="Zhang X."/>
<person name="Zhou R."/>
</authorList>
<dbReference type="PubMed" id="22570727"/>
<dbReference type="DOI" id="10.1371/journal.pone.0036564"/>
</citation>
<scope>CHARACTERIZATION OF VARIANTS CTRCT6 ILE-940 AND CTRCT6 TRP-948</scope>
</reference>
<comment type="function">
<text evidence="26 28 32 38 41 42 47 49 50">Receptor tyrosine kinase which binds promiscuously membrane-bound ephrin-A family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Activated by the ligand ephrin-A1/EFNA1 regulates migration, integrin-mediated adhesion, proliferation and differentiation of cells. Regulates cell adhesion and differentiation through DSG1/desmoglein-1 and inhibition of the ERK1/ERK2 (MAPK3/MAPK1, respectively) signaling pathway. May also participate in UV radiation-induced apoptosis and have a ligand-independent stimulatory effect on chemotactic cell migration. During development, may function in distinctive aspects of pattern formation and subsequently in development of several fetal tissues. Involved for instance in angiogenesis, in early hindbrain development and epithelial proliferation and branching morphogenesis during mammary gland development. Engaged by the ligand ephrin-A5/EFNA5 may regulate lens fiber cells shape and interactions and be important for lens transparency development and maintenance. With ephrin-A2/EFNA2 may play a role in bone remodeling through regulation of osteoclastogenesis and osteoblastogenesis.</text>
</comment>
<comment type="catalytic activity">
<text evidence="25 43">ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.</text>
</comment>
<comment type="subunit">
<text evidence="19 26 27 28 29 37 40 41 44 47 48">Homodimer. Interacts with SLA. Interacts (phosphorylated form) with VAV2, VAV3 and PI3-kinase p85 subunit (PIK3R1, PIK3R2 or PIK3R3); critical for the EFNA1-induced activation of RAC1 which stimulates cell migration (By similarity). Interacts with INPPL1; regulates activated EPHA2 endocytosis and degradation. Interacts (inactivated form) with PTK2/FAK1 and interacts (EFNA1 ligand-activated form) with PTPN11; regulates integrin-mediated adhesion. Interacts with ARHGEF16, DOCK4 and ELMO2; mediates ligand-independent activation of RAC1 which stimulates cell migration. Interacts with CLDN4; phosphorylates CLDN4 and may regulate tight junctions. Interacts with ACP1. Interacts (via SAM domain) with ANKS1A (via SAM domain). Interacts with CEMIP. Interacts with NCK1; may regulate EPHA2 activity in cell migration and adhesion.</text>
</comment>
<comment type="subunit">
<text evidence="46">(Microbial infection) Interacts with human herpes virus 8/HHV-8 glycoprotein L/gL and glycoprotein H/gH heterodimer; this interaction triggers EPHA2 phosphorylation and endocytosis, allowing virus entry.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-702104"/>
<interactant intactId="EBI-715194">
<id>P20827</id>
<label>EFNA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-702104"/>
<interactant intactId="EBI-1383428">
<id>Q15375</id>
<label>EPHA7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-702104"/>
<interactant intactId="EBI-352572">
<id>P08238</id>
<label>HSP90AB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-702104"/>
<interactant intactId="EBI-702142">
<id>Q05397</id>
<label>PTK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="33 38 42">Cell membrane</location>
<topology evidence="20">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="38">Cell projection</location>
<location evidence="38">Ruffle membrane</location>
<topology evidence="20">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="38">Cell projection</location>
<location evidence="38">Lamellipodium membrane</location>
<topology evidence="20">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="26">Cell junction</location>
<location evidence="26">Focal adhesion</location>
</subcellularLocation>
<text evidence="33 38 42 49">Present at regions of cell-cell contacts but also at the leading edge of migrating cells (PubMed:19573808, PubMed:20861311). Relocates from the plasma membrane to the cytoplasmic and perinuclear regions in cancer cells (PubMed:18794797).</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P29317-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P29317-2</id>
<name>2</name>
<sequence type="described" ref="VSP_056014 VSP_056015"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="30">Expressed in brain and glioma tissue and glioma cell lines (at protein level). Expressed most highly in tissues that contain a high proportion of epithelial cells, e.g. skin, intestine, lung, and ovary.</text>
</comment>
<comment type="induction">
<text evidence="32">Up-regulated by UV irradiation via a TP53-independent, MAPK-dependent mechanism.</text>
</comment>
<comment type="PTM">
<text evidence="26 33 38 47 49 50">Autophosphorylates. Phosphorylated on tyrosine upon binding and activation by EFNA1. Phosphorylated residues Tyr-588 and Tyr-594 are required for binding VAV2 and VAV3 while phosphorylated residues Tyr-735 and Tyr-930 are required for binding PI3-kinase p85 subunit (PIK3R1, PIK3R2 or PIK3R3). These phosphorylated residues are critical for recruitment of VAV2 and VAV3 and PI3-kinase p85 subunit which transduce downstream signaling to activate RAC1 GTPase and cell migration. Dephosphorylation of Tyr-930 by PTPRF prevents the interaction of EPHA2 with NCK1. Phosphorylated at Ser-897 by PKB; serum-induced phosphorylation which targets EPHA2 to the cell leading edge and stimulates cell migration. Phosphorylation by PKB is inhibited by EFNA1-activated EPHA2 which regulates PKB activity via a reciprocal regulatory loop. Phosphorylated at Ser-897 in response to TNF by RPS6KA1 and RPS6KA3; RPS6KA-EPHA2 signaling pathway controls cell migration (PubMed:26158630). Phosphorylated at Ser-897 by PKA; blocks cell retraction induced by EPHA2 kinase activity (PubMed:27385333). Dephosphorylated by ACP1.</text>
</comment>
<comment type="PTM">
<text evidence="18">Ubiquitinated by CHIP/STUB1. Ubiquitination is regulated by the HSP90 chaperone and regulates the receptor stability and activity through proteasomal degradation. ANKS1A prevents ubiquitination and degradation (By similarity).</text>
</comment>
<comment type="disease" evidence="34 36 39 45">
<disease id="DI-02506">
<name>Cataract 6, multiple types</name>
<acronym>CTRCT6</acronym>
<description>An opacification of the crystalline lens of the eye that frequently results in visual impairment or blindness. Opacities vary in morphology, are often confined to a portion of the lens, and may be static or progressive. CTRCT6 includes posterior polar and age-related cortical cataracts, among others. Posterior polar cataract is a subcapsular opacity, usually disk-shaped, located at the back of the lens. Age-related cortical cataract is a developmental punctate opacity restricted to the cortex. The cataract is white or cerulean, increases in number with age, but rarely affects vision.</description>
<dbReference type="MIM" id="116600"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<text evidence="38">Overexpressed in several cancer types and promotes malignancy.</text>
</comment>
<comment type="similarity">
<text evidence="21">Belongs to the protein kinase superfamily. Tyr protein kinase family. Ephrin receptor subfamily.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/EPHA2ID40462ch1p36.html"/>
</comment>
<dbReference type="EC" id="2.7.10.1"/>
<dbReference type="EMBL" id="M59371">
<property type="protein sequence ID" value="AAA53375.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="EU826606">
<property type="protein sequence ID" value="ACF47642.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL451042">
<property type="protein sequence ID" value="CAH71943.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471167">
<property type="protein sequence ID" value="EAW51769.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC037166">
<property type="protein sequence ID" value="AAH37166.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS169.1">
<molecule id="P29317-1"/>
</dbReference>
<dbReference type="PIR" id="A36355">
<property type="entry name" value="A36355"/>
</dbReference>
<dbReference type="RefSeq" id="NP_004422.2">
<molecule id="P29317-1"/>
<property type="nucleotide sequence ID" value="NM_004431.4"/>
</dbReference>
<dbReference type="UniGene" id="Hs.171596"/>
<dbReference type="PDB" id="1MQB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B=596-900"/>
</dbReference>
<dbReference type="PDB" id="2E8N">
<property type="method" value="NMR"/>
<property type="chains" value="A=902-976"/>
</dbReference>
<dbReference type="PDB" id="2K9Y">
<property type="method" value="NMR"/>
<property type="chains" value="A/B=523-563"/>
</dbReference>
<dbReference type="PDB" id="2KSO">
<property type="method" value="NMR"/>
<property type="chains" value="A=908-972"/>
</dbReference>
<dbReference type="PDB" id="2X10">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A=27-534"/>
</dbReference>
<dbReference type="PDB" id="2X11">
<property type="method" value="X-ray"/>
<property type="resolution" value="4.83"/>
<property type="chains" value="A=27-534"/>
</dbReference>
<dbReference type="PDB" id="3C8X">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.95"/>
<property type="chains" value="A=23-202"/>
</dbReference>
<dbReference type="PDB" id="3CZU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.65"/>
<property type="chains" value="A=23-202"/>
</dbReference>
<dbReference type="PDB" id="3FL7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=23-531"/>
</dbReference>
<dbReference type="PDB" id="3HEI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A/C/E/G/I/K/M/O=28-201"/>
</dbReference>
<dbReference type="PDB" id="3HPN">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.52"/>
<property type="chains" value="A/B/C/D/E/F=28-201"/>
</dbReference>
<dbReference type="PDB" id="3KKA">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="C/D/E=903-971"/>
</dbReference>
<dbReference type="PDB" id="3MBW">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.81"/>
<property type="chains" value="A=23-326"/>
</dbReference>
<dbReference type="PDB" id="3MX0">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.51"/>
<property type="chains" value="A/C=27-435"/>
</dbReference>
<dbReference type="PDB" id="3SKJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="E/F=23-202"/>
</dbReference>
<dbReference type="PDB" id="4P2K">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.50"/>
<property type="chains" value="A=590-876"/>
</dbReference>
<dbReference type="PDB" id="4PDO">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A/B=590-876"/>
</dbReference>
<dbReference type="PDB" id="4TRL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.45"/>
<property type="chains" value="A=590-876"/>
</dbReference>
<dbReference type="PDB" id="5EK7">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A/B=583-876"/>
</dbReference>
<dbReference type="PDB" id="5I9U">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.89"/>
<property type="chains" value="A=596-900"/>
</dbReference>
<dbReference type="PDB" id="5I9V">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.46"/>
<property type="chains" value="A=596-900"/>
</dbReference>
<dbReference type="PDB" id="5I9W">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.36"/>
<property type="chains" value="A=596-900"/>
</dbReference>
<dbReference type="PDB" id="5I9X">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.43"/>
<property type="chains" value="A=596-900"/>
</dbReference>
<dbReference type="PDB" id="5I9Y">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.23"/>
<property type="chains" value="A=596-900"/>
</dbReference>
<dbReference type="PDB" id="5I9Z">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=596-900"/>
</dbReference>
<dbReference type="PDB" id="5IA0">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.95"/>
<property type="chains" value="A/B/C=596-900"/>
</dbReference>
<dbReference type="PDB" id="5IA1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.04"/>
<property type="chains" value="A=596-900"/>
</dbReference>
<dbReference type="PDB" id="5IA2">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.62"/>
<property type="chains" value="A=596-900"/>
</dbReference>
<dbReference type="PDB" id="5IA3">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.79"/>
<property type="chains" value="A=596-900"/>
</dbReference>
<dbReference type="PDB" id="5IA4">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=596-900"/>
</dbReference>
<dbReference type="PDB" id="5IA5">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.78"/>
<property type="chains" value="A=596-900"/>
</dbReference>
<dbReference type="PDBsum" id="1MQB"/>
<dbReference type="PDBsum" id="2E8N"/>
<dbReference type="PDBsum" id="2K9Y"/>
<dbReference type="PDBsum" id="2KSO"/>
<dbReference type="PDBsum" id="2X10"/>
<dbReference type="PDBsum" id="2X11"/>
<dbReference type="PDBsum" id="3C8X"/>
<dbReference type="PDBsum" id="3CZU"/>
<dbReference type="PDBsum" id="3FL7"/>
<dbReference type="PDBsum" id="3HEI"/>
<dbReference type="PDBsum" id="3HPN"/>
<dbReference type="PDBsum" id="3KKA"/>
<dbReference type="PDBsum" id="3MBW"/>
<dbReference type="PDBsum" id="3MX0"/>
<dbReference type="PDBsum" id="3SKJ"/>
<dbReference type="PDBsum" id="4P2K"/>
<dbReference type="PDBsum" id="4PDO"/>
<dbReference type="PDBsum" id="4TRL"/>
<dbReference type="PDBsum" id="5EK7"/>
<dbReference type="PDBsum" id="5I9U"/>
<dbReference type="PDBsum" id="5I9V"/>
<dbReference type="PDBsum" id="5I9W"/>
<dbReference type="PDBsum" id="5I9X"/>
<dbReference type="PDBsum" id="5I9Y"/>
<dbReference type="PDBsum" id="5I9Z"/>
<dbReference type="PDBsum" id="5IA0"/>
<dbReference type="PDBsum" id="5IA1"/>
<dbReference type="PDBsum" id="5IA2"/>
<dbReference type="PDBsum" id="5IA3"/>
<dbReference type="PDBsum" id="5IA4"/>
<dbReference type="PDBsum" id="5IA5"/>
<dbReference type="ProteinModelPortal" id="P29317"/>
<dbReference type="SMR" id="P29317"/>
<dbReference type="BioGrid" id="108288">
<property type="interactions" value="67"/>
</dbReference>
<dbReference type="DIP" id="DIP-96N"/>
<dbReference type="IntAct" id="P29317">
<property type="interactions" value="30"/>
</dbReference>
<dbReference type="MINT" id="MINT-3972729"/>
<dbReference type="STRING" id="9606.ENSP00000351209"/>
<dbReference type="BindingDB" id="P29317"/>
<dbReference type="ChEMBL" id="CHEMBL2068"/>
<dbReference type="DrugBank" id="DB01254">
<property type="generic name" value="Dasatinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB04395">
<property type="generic name" value="Phosphoaminophosphonic Acid-Adenylate Ester"/>
</dbReference>
<dbReference type="DrugBank" id="DB08896">
<property type="generic name" value="Regorafenib"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="1822"/>
<dbReference type="iPTMnet" id="P29317"/>
<dbReference type="PhosphoSitePlus" id="P29317"/>
<dbReference type="SwissPalm" id="P29317"/>
<dbReference type="UniCarbKB" id="P29317"/>
<dbReference type="BioMuta" id="EPHA2"/>
<dbReference type="DMDM" id="229462861"/>
<dbReference type="EPD" id="P29317"/>
<dbReference type="MaxQB" id="P29317"/>
<dbReference type="PaxDb" id="P29317"/>
<dbReference type="PeptideAtlas" id="P29317"/>
<dbReference type="PRIDE" id="P29317"/>
<dbReference type="DNASU" id="1969"/>
<dbReference type="Ensembl" id="ENST00000358432">
<molecule id="P29317-1"/>
<property type="protein sequence ID" value="ENSP00000351209"/>
<property type="gene ID" value="ENSG00000142627"/>
</dbReference>
<dbReference type="GeneID" id="1969"/>
<dbReference type="KEGG" id="hsa:1969"/>
<dbReference type="UCSC" id="uc001aya.2">
<molecule id="P29317-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="1969"/>
<dbReference type="DisGeNET" id="1969"/>
<dbReference type="GeneCards" id="EPHA2"/>
<dbReference type="HGNC" id="HGNC:3386">
<property type="gene designation" value="EPHA2"/>
</dbReference>
<dbReference type="HPA" id="HPA066055"/>
<dbReference type="MalaCards" id="EPHA2"/>
<dbReference type="MIM" id="116600">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="176946">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P29317"/>
<dbReference type="OpenTargets" id="ENSG00000142627"/>
<dbReference type="Orphanet" id="98993">
<property type="disease" value="Posterior polar cataract"/>
</dbReference>
<dbReference type="Orphanet" id="98994">
<property type="disease" value="Total congenital cataract"/>
</dbReference>
<dbReference type="PharmGKB" id="PA27818"/>
<dbReference type="eggNOG" id="KOG0196">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG0515">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000118975"/>
<dbReference type="HOGENOM" id="HOG000233856"/>
<dbReference type="HOVERGEN" id="HBG062180"/>
<dbReference type="InParanoid" id="P29317"/>
<dbReference type="KO" id="K05103"/>
<dbReference type="OMA" id="CSPGFFK"/>
<dbReference type="OrthoDB" id="EOG091G00W0"/>
<dbReference type="PhylomeDB" id="P29317"/>
<dbReference type="TreeFam" id="TF315608"/>
<dbReference type="BRENDA" id="2.7.10.1">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2682334">
<property type="pathway name" value="EPH-Ephrin signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3928663">
<property type="pathway name" value="EPHA-mediated growth cone collapse"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3928665">
<property type="pathway name" value="EPH-ephrin mediated repulsion of cells"/>
</dbReference>
<dbReference type="SignaLink" id="P29317"/>
<dbReference type="SIGNOR" id="P29317"/>
<dbReference type="EvolutionaryTrace" id="P29317"/>
<dbReference type="GeneWiki" id="EPH_receptor_A2"/>
<dbReference type="GenomeRNAi" id="1969"/>
<dbReference type="PRO" id="PR:P29317"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 1"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000142627"/>
<dbReference type="CleanEx" id="HS_EPHA2"/>
<dbReference type="ExpressionAtlas" id="P29317">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P29317">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0009986">
<property type="term" value="C:cell surface"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005925">
<property type="term" value="C:focal adhesion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005622">
<property type="term" value="C:intracellular"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="GOC"/>
</dbReference>
<dbReference type="GO" id="GO:0030027">
<property type="term" value="C:lamellipodium"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031258">
<property type="term" value="C:lamellipodium membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0031256">
<property type="term" value="C:leading edge membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032587">
<property type="term" value="C:ruffle membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0045296">
<property type="term" value="F:cadherin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005003">
<property type="term" value="F:ephrin receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0004714">
<property type="term" value="F:transmembrane receptor protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090630">
<property type="term" value="P:activation of GTPase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048320">
<property type="term" value="P:axial mesoderm formation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002043">
<property type="term" value="P:blood vessel endothelial cell proliferation involved in sprouting angiogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046849">
<property type="term" value="P:bone remodeling"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060444">
<property type="term" value="P:branching involved in mammary gland duct morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046058">
<property type="term" value="P:cAMP metabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007155">
<property type="term" value="P:cell adhesion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0060326">
<property type="term" value="P:cell chemotaxis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016477">
<property type="term" value="P:cell migration"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048870">
<property type="term" value="P:cell motility"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050830">
<property type="term" value="P:defense response to Gram-positive bacterium"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048013">
<property type="term" value="P:ephrin receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008630">
<property type="term" value="P:intrinsic apoptotic signaling pathway in response to DNA damage"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030216">
<property type="term" value="P:keratinocyte differentiation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070309">
<property type="term" value="P:lens fiber cell morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0033598">
<property type="term" value="P:mammary gland epithelial cell proliferation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007275">
<property type="term" value="P:multicellular organism development"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0016525">
<property type="term" value="P:negative regulation of angiogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032682">
<property type="term" value="P:negative regulation of chemokine production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1901491">
<property type="term" value="P:negative regulation of lymphangiogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051898">
<property type="term" value="P:negative regulation of protein kinase B signaling"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0021915">
<property type="term" value="P:neural tube development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030182">
<property type="term" value="P:neuron differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060035">
<property type="term" value="P:notochord cell development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0014028">
<property type="term" value="P:notochord formation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001649">
<property type="term" value="P:osteoblast differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030316">
<property type="term" value="P:osteoclast differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1904238">
<property type="term" value="P:pericyte cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0090004">
<property type="term" value="P:positive regulation of establishment of protein localization to plasma membrane"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0036342">
<property type="term" value="P:post-anal tail morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043491">
<property type="term" value="P:protein kinase B signaling"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045765">
<property type="term" value="P:regulation of angiogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043535">
<property type="term" value="P:regulation of blood vessel endothelial cell migration"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0033628">
<property type="term" value="P:regulation of cell adhesion mediated by integrin"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070372">
<property type="term" value="P:regulation of ERK1 and ERK2 cascade"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010591">
<property type="term" value="P:regulation of lamellipodium assembly"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070848">
<property type="term" value="P:response to growth factor"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001501">
<property type="term" value="P:skeletal system development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001570">
<property type="term" value="P:vasculogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016032">
<property type="term" value="P:viral process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="CDD" id="cd10480">
<property type="entry name" value="EphR_LBD_A2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="CDD" id="cd00063">
<property type="entry name" value="FN3"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.120.260">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="2"/>
</dbReference>
<dbReference type="InterPro" id="IPR027936">
<property type="entry name" value="Eph_TM"/>
</dbReference>
<dbReference type="InterPro" id="IPR034263">
<property type="entry name" value="EphA2_rcpt_lig-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR001090">
<property type="entry name" value="Ephrin_rcpt_lig-bd_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR003961">
<property type="entry name" value="FN3_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR008979">
<property type="entry name" value="Galactose-bd-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR009030">
<property type="entry name" value="Growth_fac_rcpt_"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR001660">
<property type="entry name" value="SAM"/>
</dbReference>
<dbReference type="InterPro" id="IPR013761">
<property type="entry name" value="SAM/pointed"/>
</dbReference>
<dbReference type="InterPro" id="IPR001245">
<property type="entry name" value="Ser-Thr/Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR011641">
<property type="entry name" value="Tyr-kin_ephrin_A/B_rcpt-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR008266">
<property type="entry name" value="Tyr_kinase_AS"/>
</dbReference>
<dbReference type="InterPro" id="IPR020635">
<property type="entry name" value="Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR016257">
<property type="entry name" value="Tyr_kinase_ephrin_rcpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR001426">
<property type="entry name" value="Tyr_kinase_rcpt_V_CS"/>
</dbReference>
<dbReference type="Pfam" id="PF14575">
<property type="entry name" value="EphA2_TM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01404">
<property type="entry name" value="Ephrin_lbd"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00041">
<property type="entry name" value="fn3"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF07714">
<property type="entry name" value="Pkinase_Tyr"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00536">
<property type="entry name" value="SAM_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF000666">
<property type="entry name" value="TyrPK_ephrin_receptor"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00109">
<property type="entry name" value="TYRKINASE"/>
</dbReference>
<dbReference type="SMART" id="SM00615">
<property type="entry name" value="EPH_lbd"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM01411">
<property type="entry name" value="Ephrin_rec_like"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00060">
<property type="entry name" value="FN3"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00454">
<property type="entry name" value="SAM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00219">
<property type="entry name" value="TyrKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF47769">
<property type="entry name" value="SSF47769"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF49265">
<property type="entry name" value="SSF49265"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF49785">
<property type="entry name" value="SSF49785"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF57184">
<property type="entry name" value="SSF57184"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS51550">
<property type="entry name" value="EPH_LBD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50853">
<property type="entry name" value="FN3"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00109">
<property type="entry name" value="PROTEIN_KINASE_TYR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00790">
<property type="entry name" value="RECEPTOR_TYR_KIN_V_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00791">
<property type="entry name" value="RECEPTOR_TYR_KIN_V_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50105">
<property type="entry name" value="SAM_DOMAIN"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0037">Angiogenesis</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0898">Cataract</keyword>
<keyword id="KW-0130">Cell adhesion</keyword>
<keyword id="KW-0965">Cell junction</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0966">Cell projection</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0221">Differentiation</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0829">Tyrosine-protein kinase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="signal peptide" evidence="20">
<location>
<begin position="1"/>
<end position="23"/>
</location>
</feature>
<feature type="chain" description="Ephrin type-A receptor 2" id="PRO_0000016800">
<location>
<begin position="24"/>
<end position="976"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="20">
<location>
<begin position="24"/>
<end position="537"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="20">
<location>
<begin position="538"/>
<end position="558"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="20">
<location>
<begin position="559"/>
<end position="976"/>
</location>
</feature>
<feature type="domain" description="Eph LBD" evidence="24">
<location>
<begin position="28"/>
<end position="206"/>
</location>
</feature>
<feature type="domain" description="Fibronectin type-III 1" evidence="23">
<location>
<begin position="328"/>
<end position="432"/>
</location>
</feature>
<feature type="domain" description="Fibronectin type-III 2" evidence="23">
<location>
<begin position="438"/>
<end position="529"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="21">
<location>
<begin position="613"/>
<end position="875"/>
</location>
</feature>
<feature type="domain" description="SAM" evidence="22">
<location>
<begin position="904"/>
<end position="968"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="21">
<location>
<begin position="619"/>
<end position="627"/>
</location>
</feature>
<feature type="region of interest" description="Mediates interaction with CLDN4" evidence="28">
<location>
<begin position="1"/>
<end position="206"/>
</location>
</feature>
<feature type="region of interest" description="Mediates interaction with ARHGEF16 and ELMO2" evidence="41">
<location>
<begin position="606"/>
<end position="906"/>
</location>
</feature>
<feature type="region of interest" description="Negatively regulates interaction with ARHGEF16" evidence="41">
<location>
<begin position="886"/>
<end position="976"/>
</location>
</feature>
<feature type="short sequence motif" description="PDZ-binding" evidence="20">
<location>
<begin position="974"/>
<end position="976"/>
</location>
</feature>
<feature type="compositionally biased region" description="Cys-rich">
<location>
<begin position="188"/>
<end position="325"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="21 25">
<location>
<position position="739"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="21">
<location>
<position position="646"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14 15 16">
<location>
<position position="570"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="17">
<location>
<position position="575"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="15">
<location>
<position position="579"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="18">
<location>
<position position="588"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="19">
<location>
<position position="594"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="16">
<location>
<position position="628"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="15 16">
<location>
<position position="647"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="18">
<location>
<position position="735"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="19">
<location>
<position position="772"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="16">
<location>
<position position="869"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14 17">
<location>
<position position="892"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PKB/AKT1, RPS6KA1, RPS6KA3 AND PKA" evidence="17 38 49 50">
<location>
<position position="897"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14 17 50">
<location>
<position position="901"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="20">
<location>
<position position="921"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="47">
<location>
<position position="930"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="20">
<location>
<position position="407"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="35">
<location>
<position position="435"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="70"/>
<end position="188"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="105"/>
<end position="115"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_056014" evidence="51">
<original>GDSNSYNVRRTEGFSVTLDDL</original>
<variation>VTPRGAGLALAGPTAGDRLVT</variation>
<location>
<begin position="477"/>
<end position="497"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_056015" evidence="51">
<location>
<begin position="498"/>
<end position="976"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1058372." id="VAR_055989">
<original>K</original>
<variation>N</variation>
<location>
<position position="99"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34192549." id="VAR_042121" evidence="31">
<original>G</original>
<variation>R</variation>
<location>
<position position="391"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs55747232." id="VAR_042122" evidence="31">
<original>T</original>
<variation>M</variation>
<location>
<position position="511"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56198600." id="VAR_042123" evidence="31">
<original>R</original>
<variation>H</variation>
<location>
<position position="568"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34021505." id="VAR_055990">
<original>M</original>
<variation>T</variation>
<location>
<position position="631"/>
</location>
</feature>
<feature type="sequence variant" description="In CTRCT6; retained in the cytoplasm and constitutively active it alters EPHA2 signaling; dbSNP:rs116506614." id="VAR_062532" evidence="39">
<original>R</original>
<variation>Q</variation>
<location>
<position position="721"/>
</location>
</feature>
<feature type="sequence variant" description="In a gastric adenocarcinoma sample; somatic mutation." id="VAR_042124" evidence="31">
<original>G</original>
<variation>S</variation>
<location>
<position position="777"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35903225." id="VAR_042125" evidence="31">
<original>R</original>
<variation>H</variation>
<location>
<position position="876"/>
</location>
</feature>
<feature type="sequence variant" description="In CTRCT6; reduced protein stability and reduced ability to stimulate cell migration in absence of its ephrin ligand; dbSNP:rs137853200." id="VAR_058907" evidence="36 45">
<original>T</original>
<variation>I</variation>
<location>
<position position="940"/>
</location>
</feature>
<feature type="sequence variant" description="In CTRCT6; reduced protein stability and reduced ability to stimulate cell migration in absence of its ephrin ligand; dbSNP:rs137853199." id="VAR_058908" evidence="34 45">
<original>G</original>
<variation>W</variation>
<location>
<position position="948"/>
</location>
</feature>
<feature type="mutagenesis site" description="Significantly reduced response to EFNA1." evidence="37">
<original>R</original>
<variation>E</variation>
<location>
<position position="103"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of kinase activity." evidence="28">
<original>K</original>
<variation>M</variation>
<location>
<position position="646"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increases serum-induced chemotaxis. Loss of EFNA1-dependent regulation of cell migration." evidence="38">
<original>D</original>
<variation>N</variation>
<location>
<position position="739"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of serum-induced phosphorylation by PKB. Loss of serum-induced chemotaxis." evidence="38">
<original>S</original>
<variation>A</variation>
<variation>D</variation>
<location>
<position position="897"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA53375." ref="1" evidence="52">
<original>IFIELK</original>
<variation>NNFELN</variation>
<location>
<begin position="94"/>
<end position="99"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="28"/>
<end position="33"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="34"/>
<end position="36"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="37"/>
<end position="40"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="44"/>
<end position="57"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="59"/>
<end position="62"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="64"/>
<end position="69"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="73"/>
<end position="76"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="79"/>
<end position="82"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="92"/>
<end position="103"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="105"/>
<end position="107"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="108"/>
<end position="110"/>
</location>
</feature>
<feature type="turn" evidence="8">
<location>
<begin position="112"/>
<end position="114"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="119"/>
<end position="128"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="136"/>
<end position="138"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="139"/>
<end position="145"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="148"/>
<end position="151"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="153"/>
<end position="157"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="161"/>
<end position="170"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="175"/>
<end position="187"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="189"/>
<end position="199"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="204"/>
<end position="206"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="209"/>
<end position="211"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="218"/>
<end position="221"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="224"/>
<end position="227"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="238"/>
<end position="240"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="244"/>
<end position="247"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="253"/>
<end position="257"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="266"/>
<end position="269"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="272"/>
<end position="275"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="286"/>
<end position="288"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="295"/>
<end position="298"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="335"/>
<end position="338"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="343"/>
<end position="348"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="361"/>
<end position="369"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="376"/>
<end position="378"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="384"/>
<end position="387"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="389"/>
<end position="392"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="394"/>
<end position="400"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="407"/>
<end position="415"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="419"/>
<end position="421"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="427"/>
<end position="433"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="441"/>
<end position="446"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="453"/>
<end position="457"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="460"/>
<end position="465"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="467"/>
<end position="475"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="483"/>
<end position="493"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="502"/>
<end position="510"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="522"/>
<end position="525"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="536"/>
<end position="556"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="557"/>
<end position="561"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="591"/>
<end position="594"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="597"/>
<end position="600"/>
</location>
</feature>
<feature type="helix" evidence="12">
<location>
<begin position="601"/>
<end position="604"/>
</location>
</feature>
<feature type="helix" evidence="12">
<location>
<begin position="610"/>
<end position="612"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="613"/>
<end position="621"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="623"/>
<end position="625"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="626"/>
<end position="632"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="635"/>
<end position="637"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="641"/>
<end position="648"/>
</location>
</feature>
<feature type="helix" evidence="12">
<location>
<begin position="654"/>
<end position="667"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="678"/>
<end position="682"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="684"/>
<end position="693"/>
</location>
</feature>
<feature type="helix" evidence="12">
<location>
<begin position="700"/>
<end position="706"/>
</location>
</feature>
<feature type="turn" evidence="12">
<location>
<begin position="707"/>
<end position="709"/>
</location>
</feature>
<feature type="helix" evidence="12">
<location>
<begin position="713"/>
<end position="732"/>
</location>
</feature>
<feature type="helix" evidence="12">
<location>
<begin position="742"/>
<end position="744"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="745"/>
<end position="747"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="753"/>
<end position="755"/>
</location>
</feature>
<feature type="helix" evidence="12">
<location>
<begin position="762"/>
<end position="766"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="776"/>
<end position="779"/>
</location>
</feature>
<feature type="helix" evidence="12">
<location>
<begin position="781"/>
<end position="783"/>
</location>
</feature>
<feature type="helix" evidence="12">
<location>
<begin position="786"/>
<end position="791"/>
</location>
</feature>
<feature type="helix" evidence="12">
<location>
<begin position="796"/>
<end position="811"/>
</location>
</feature>
<feature type="turn" evidence="12">
<location>
<begin position="817"/>
<end position="820"/>
</location>
</feature>
<feature type="helix" evidence="12">
<location>
<begin position="823"/>
<end position="831"/>
</location>
</feature>
<feature type="helix" evidence="12">
<location>
<begin position="844"/>
<end position="853"/>
</location>
</feature>
<feature type="helix" evidence="12">
<location>
<begin position="858"/>
<end position="860"/>
</location>
</feature>
<feature type="helix" evidence="12">
<location>
<begin position="864"/>
<end position="876"/>
</location>
</feature>
<feature type="helix" evidence="12">
<location>
<begin position="878"/>
<end position="882"/>
</location>
</feature>
<feature type="helix" evidence="13">
<location>
<begin position="884"/>
<end position="887"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="909"/>
<end position="915"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="919"/>
<end position="921"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="922"/>
<end position="927"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="933"/>
<end position="937"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="941"/>
<end position="946"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="952"/>
<end position="964"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2K9Y"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3C8X"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3FL7"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3HEI"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3HPN"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3KKA"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3MBW"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3SKJ"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4PDO"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5EK7"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5I9V"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5I9Y"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5IA0"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19369195"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000250"/>
<evidence key="19" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q03145"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000255"/>
<evidence key="21" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00184"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00316"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00883"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10028"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10655584"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12167657"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16236711"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17135240"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17332925"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18339848"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18794797"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19005574"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19159218"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19306328"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19525919"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19573808"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19649315"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20505120"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20679435"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20861311"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2174105"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22332920"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22570727"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22635007"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23358419"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23936024"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26158630"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27385333"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="18593464"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000305"/>
<sequence length="976" mass="108266" checksum="845D7E1BBCCAACCC" modified="2009-05-05" version="2" precursor="true">
MELQAARACFALLWGCALAAAAAAQGKEVVLLDFAAAGGELGWLTHPYGKGWDLMQNIMN
DMPIYMYSVCNVMSGDQDNWLRTNWVYRGEAERIFIELKFTVRDCNSFPGGASSCKETFN
LYYAESDLDYGTNFQKRLFTKIDTIAPDEITVSSDFEARHVKLNVEERSVGPLTRKGFYL
AFQDIGACVALLSVRVYYKKCPELLQGLAHFPETIAGSDAPSLATVAGTCVDHAVVPPGG
EEPRMHCAVDGEWLVPIGQCLCQAGYEKVEDACQACSPGFFKFEASESPCLECPEHTLPS
PEGATSCECEEGFFRAPQDPASMPCTRPPSAPHYLTAVGMGAKVELRWTPPQDSGGREDI
VYSVTCEQCWPESGECGPCEASVRYSEPPHGLTRTSVTVSDLEPHMNYTFTVEARNGVSG
LVTSRSFRTASVSINQTEPPKVRLEGRSTTSLSVSWSIPPPQQSRVWKYEVTYRKKGDSN
SYNVRRTEGFSVTLDDLAPDTTYLVQVQALTQEGQGAGSKVHEFQTLSPEGSGNLAVIGG
VAVGVVLLLVLAGVGFFIHRRRKNQRARQSPEDVYFSKSEQLKPLKTYVDPHTYEDPNQA
VLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDF
LGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGML
RGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP
IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPM
DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADFDPRVSIRLPSTSG
SEGVPFRTVSEWLESIKMQQYTEHFMAAGYTAIEKVVQMTNDDIKRIGVRLPGHQKRIAY
SLLGLKDQVNTVGIPI
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>